On the cost and safety of medicines, research, ageing, the questions around healthcare rights, medical evidence and more
For anyone navigating the healthcare system, diagnosis is only the harsh beginning. There are medicines to afford, compulsive researching, decisions to make, follow-up appointments to keep and, sometimes, conflicting advice to sort through. For people living with chronic illnesses and disabilities, these become part of everyday life. The question is not only whether medical science can offer a treatment, but whether the care is in reach and if one can understand their options and make informed decisions about their health. A few of this week’s reports look at these questions
Treatment and questions
The government has capped trade margins on 137 anti-cancer drugs, as Bindu Shajan Perappadan reported. The move brings the discourse on the cost of cancer treatment back into focus. For patients and their families, the price of medicines can influence how manageable treatment is over months or years. A price cap is an important policy intervention, but its real value will depend on whether patients see meaningful savings.
And in Keralam, parents of children with spinal muscular atrophy have sought political support over concerns about a generic drug. For families dealing with a rare condition, access to treatment can involve difficult decisions about affordability and the medicines available to them. These decisions need clear communication and reliable evidence on safety and effectiveness, alongside efforts to make treatment accessible.
There is also the question of the use of medication and Dr. Chandrakant Lahariya examines India’s problem of overtreatment and overmedication. Unnecessary tests and medicines can add costs and expose patients to avoidable risks. For people already managing several conditions or taking multiple medicines, knowing what is necessary and what may not be is an important part of safe care.
What new research tells us
I write about lung adenocarcinoma in the all you need to know about series, following news that Pope Leo XIV underwent surgery for the cancer. The Vatican later said his recovery was on track. The explainer looks at the disease behind the headlines and offers readers a clearer understanding of this type of lung cancer.
Other research this week looks at how differently people can experience disease. A study suggests that early-onset Alzheimer’s disease can look very different from the late-onset form. Another suggests that menopause may involve a more pronounced physiological shift around the final menstrual period than the idea of a gradual transition implies.
Long COVID remains another area where researchers are working to understand why some people continue to experience effects long after an infection. A new study suggests that the condition may affect bacteria in the mouth and lungs. It is still too early to conclude what these changes mean for persistent symptoms, but the research adds to efforts to understand the longer-term effects of COVID-19.
Science, integrity and disease detection
An analysis of more than 4,000 cancer research articles has identified suspected paper-mill activity, raising concerns about the reliability of published research. Scientific findings often become the starting point for further studies, so potentially fraudulent papers can have consequences well beyond the journals in which they appear. Trust in science depends not just on new discoveries, but also on how carefully the evidence is produced and checked.
V. Geetanath reports on a genetic toolkit developed by scientists at the Centre for Cellular and Molecular Biology to study the inner workings of tuberculosis. The tool could help researchers investigate the bacterium more closely. It is an example of the foundational work that often happens long before a discovery leads to a new test or treatment.
Another report looks at chemical signatures -- patterns of molecules and compounds in the body that could help identify diseases by detecting changes associated with illness. These signatures may offer clues to disease processes and support earlier diagnosis, but researchers must establish how accurately they can identify specific conditions and distinguish them from other causes of similar changes. The challenge is to validate these findings in different patient groups and develop tests that are reliable, clinically useful and accessible in routine healthcare.
Climate and community health
The health effects of climate change are not always immediately visible, but their potential scale is considerable. An analysis suggests that limiting global warming to 1.8°C could prevent the loss of 1.89 billion years of healthy life. The estimate puts the consequences of a warming planet in terms of human health, reminding us that the conditions in which people live are closely tied to their ability to stay well.
Closer home, Kozhikode has reported 161 confirmed measles cases and one death. C. Maya reports that a continuing mumps outbreak in Keralam has also renewed demands for the measles, mumps and rubella vaccine.
Care also needs to continue beyond the immediate event that brings someone into the health system. Dr. Sowmya Josyula writes about why maternal health care after delivery is crucial. Once a baby is born, attention can shift almost entirely to the newborn, even though the mother may still need medical follow-up and support. Postpartum care is an essential part of maternal healthcare, not an optional extra.
Sudha Chandrashekar’s article on making Keralam age-ready takes up a related question: how can the rights of the elderly be translated into accessible care? Recognising those rights is only a starting point. Older people need services and support that work in practice and respect their needs and autonomy. In another important piece, Dr. Parth Sharma examines how doctors working with marginalised communities risk facing reprisals when they challenge the conditions that make people sick, from displacement and hunger to the denial of basic healthcare.
And more
Elysia Poggi Davis, Benjamin L. Hankin and Catherine Demers write in The Conversation about research suggesting that treating depression during pregnancy may benefit a baby’s brain development.
Preeti Zachariah examines why whey protein prices are rising in India.
Smruthi Prabhu explains what intestinal gas can tell us about gastrointestinal health.
Biju Dharmapalan looks at whether a sugar-rich diet while taking antibiotics could affect the gut microbiome, he also writes about why citizens should be research partners in science.
Zubeda Hamid’s In Focus podcast examines the plague case in Siberia, what is known about the disease and what remains uncertain.
In Say Her Name series, Ramya Kannan revisits the story of India’s first woman Surgeon General and the barriers she faced in pursuing a place in science.
Divya Gandhi reports on a study suggesting that wealthier Indians may be more prone to heart disease than poorer groups.
Anirban Mukhopadhyay explores a molecule that could help make treatments for inflammatory bowel disease more effective.
Dr. C. Aravinda examines how AI-MedTech is regulated in India.
Dr. Dinesh Arab reflects on health and ageing in The back end of 55.
Dr. Sushma Gopalan explore how too many treatment options can complicate decisions for patients and doctors.
Ahd here is a quiz to test readers’ knowledge of arthritis.
Also watch this special episode of Health Wrap, Episode 55 marking world sight day
(There is much more, do head to ourhealth pageand subscribe to the health newsletterhere)